Renal Biomarkers Market

Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney injuries, which are characterized by the rapid or gradual loss of kidney function resulting into serous clinical implications.

Renal Biomarkers Market contains market size and forecasts of Renal Biomarkers in Global, including the following market information:

• Global Renal Biomarkers Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Renal Biomarkers market was valued at 1202.5 million in 2021 and is projected to reach US$ 1657.2 million by 2028, at a CAGR of 4.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Enzyme Linked Immunosorbent Assay (ELISA) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Renal Biomarkers include Abbott Diagnostics, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, Astute Medical, BioMerieux SA and Randox Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Renal Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Renal Biomarkers Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Renal Biomarkers Market Segment Percentages, by Type, 2021 (%)

• Enzyme Linked Immunosorbent Assay (ELISA)
• Enzymatic Assay
• Turbidimetric Immunoassay
• Others

Global Renal Biomarkers Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Renal Biomarkers Market Segment Percentages, by Application, 2021 (%)

• Diagnosis and Disease Progression Monitoring
• Research
• Others

Global Renal Biomarkers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Renal Biomarkers Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Renal Biomarkers revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Renal Biomarkers revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Diagnostics
• F. Hoffmann-La Roche
• Beckman Coulter
• Siemens Healthcare Diagnostics
• Thermo Fisher Scientific
• Astute Medical
• BioMerieux SA
• Randox Laboratories